In Vivo is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dako Corp.

Division of Agilent Technologies Inc.
www.dakousa.com

Latest From Dako Corp.

Lung Cancer Survival Data May Help Merck’s Keytruda Catch Up

Top-line data from KEYNOTE-010 suggest opportunity for Keytruda to broaden its reach to a wider population with lower expression of the PD-L1 biomarker.

BioPharmaceutical Clinical Trials

Keeping Track: Alkermes' Aristada Approval; Bristol's Daklinza Submission; Lilly's Breakthrough

The latest drug development news and highlights from our FDA Performance Tracker.

BioPharmaceutical Regulation

Can Merck’s Keytruda Start Change In Lung Cancer Market?

With approval of Merck’s PD-1 inhibitor Keytruda and PD-L1 companion diagnostic in the valuable lung cancer indication, Wall Street’s attention starts turning toward reimbursement and commercialization.

Clinical Trials Regulation

Opdivo Back On Par With Keytruda In Lung Cancer

Though Merck’s Keytruda was recently approved for the full range of lung cancer patients, giving it a marketable advantage over the limited approval for Bristol's Opdivo in squamous disease, Bristol has caught up again with early FDA approval for the non-squamous population. FDA also added PD-L1 expression data to Opdivo’s label.

BioPharmaceutical United States
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Agilent Technologies Inc.
  • Senior Management
  • Viggo Harboe, CEO
  • Contact Info
  • Dako Corp.
    Phone: (805) 566-6655
    6392 Via Real
    Carpinteria, CA 93013
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register